Literature DB >> 2733871

Diagnosis of stress-related hyperprolactinemia. Evaluation of the hyperprolactinemia rest test.

O Muneyyirci-Delale, D Goldstein, F I Reyes.   

Abstract

It remains controversial whether two or three random estimations of prolactin (PRL) concentration obviate the need for special testing to rule out stress-related hyperprolactinemia. In order to clarify this issue, we measured PRL, cortisol, and growth hormone (GH) in serial blood samples obtained under resting conditions (HPR test) in 70 women who had had high PRL levels in two or more random blood samples. Twenty out of 70 women were found to have stress-related hyperprolactinemia, and 11 of the 20 would have been misdiagnosed by using only three random samples. Cortisol levels from the HPR test indicated stress-related pituitary adrenal reactivity in all groups, including the idiopathic (N = 30) and prolactinoma (N = 20) groups. However, PRL secretion in response to stress--a downward trend as a function of time--was evident only in the stress-related hyperprolactinemia group. These results suggest that a limited HPR test (ie, serial PRL determinations at 0, 30, and 60 min) is a valuable and simple measure to identify stress-related hyperprolactinemia in order to avoid diagnostic pitfalls and unnecessary treatment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2733871

Source DB:  PubMed          Journal:  N Y State J Med        ISSN: 0028-7628


  9 in total

Review 1.  ACP best practice no 170. Investigation of infertility with the emphasis on laboratory testing and with reference to radiological imaging.

Authors:  C Williams; T Giannopoulos; E A Sherriff
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

2.  Evaluation of stress induced by flight activity by measuring the hormonal response.

Authors:  S Farrace; R Biselli; L Urbani; C Ferlini; C De Angelis
Journal:  Biofeedback Self Regul       Date:  1996-09

Review 3.  Hyperprolactinemia.

Authors:  Jaspreet Chahal; Janet Schlechte
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

4.  Importance of cannulated prolactin test in the definition of hyperprolactinaemia.

Authors:  M B Whyte; S Pramodh; L Srikugan; J A Gilbert; J P Miell; R A Sherwood; A M McGregor; S J B Aylwin
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

Review 5.  Hyperprolactinaemia.

Authors:  Irene Samperi; Kirstie Lithgow; Niki Karavitaki
Journal:  J Clin Med       Date:  2019-12-13       Impact factor: 4.241

6.  Prolactin response to antipsychotics: An inpatient study.

Authors:  Liana Dehelean; Ana-Maria Romosan; Ion Papava; Cristina Ana Bredicean; Victor Dumitrascu; Sorin Ursoniu; Radu-Stefan Romosan
Journal:  PLoS One       Date:  2020-02-04       Impact factor: 3.240

7.  The utility of prolactin serial sampling and the best prolactin cut-offs associated with persistent hyperprolactinemia.

Authors:  Catarina Cidade-Rodrigues; Filipe M Cunha; Catarina Chaves; Margarida Silva-Vieira; André Silva; Susana Garrido; Mariana Martinho; Margarida Almeida
Journal:  Porto Biomed J       Date:  2021-04-13

Review 8.  Metabolic effects of prolactin and the role of dopamine agonists: A review.

Authors:  Polly Kirsch; Jessica Kunadia; Shruti Shah; Nidhi Agrawal
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-30       Impact factor: 6.055

9.  Utility of Cannulated Prolactin to Exclude Stress Hyperprolactinemia in Patients with Persistent Mild Hyperprolactinemia.

Authors:  Raya Almazrouei; Shamaila Zaman; Florian Wernig; Karim Meeran
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2021-06-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.